Home / Resources / Discovery resources

药物发现

最新资源

A novel mathematical framework to predict in vivo bispecific GTX-B001 binding in skin, and translation to humans

A novel mathematical framework to predict in vivo bispecific GTX-B001 binding in skin, and translation to humans

Certara Brings Chemaxon Cheminformatics Natively to Python with New Python API

Certara Brings Chemaxon Cheminformatics Natively to Python with New Python API

Expert Q&A: Identify Winning Biotherapeutics in Early Discovery

Expert Q&A: Identify Winning Biotherapeutics in Early Discovery

网络研讨会点播

Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis

Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis

精选资源

Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis

Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis

Latest discovery blogs

All Discovery - Blog

Not Just Another ChatGPT: Why Life Sciences Needs Domain-Specific AI

Mathematical Modeling and the Monkey King: Use of Modeling for More Efficient NHP Study Design

4 Ways That Mechanistic Modeling Accelerates Bispecific (and Multispecific) Antibody Drug Development

Quantitative Systems Pharmacology (QSP) Modeling for Immunotherapy-induced Cytokine Release Syndrome

药物发现平台开启科学数据访问之路

药物发现工具如何助力药物研发决策制定

在以下活动中与我们的专家会面

ACS Fall 2026

August 23 - 27, 2026 – Chicago, IL & Digital – Booth 810

BioTechX Europe 2026

2026 年 10 月 6 - 8 日

ACoP 2026

2026 年 10 月 11 - 14 日

All Discovery resources

A novel mathematical framework to predict in vivo bispecific GTX-B001 binding in skin, and translation to humans

Biologics, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - QSP, Poster

Expert Q&A: Identify Winning Biotherapeutics in Early Discovery

Biologics, Certara Products - Certara IQ, Modeling and Simulation - QSP, On-Demand Webinar

Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis

Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Publication

Trusted Cheminformatics, Zero Integration Headaches: ML in Python with Chemaxon

Certara Products, Drug Development, Webinar

Cracking the code on NCA: how Pinnacle 21 helps de-risk PK analyses

Certara Products - Pinnacle 21, Blog

Certara Compound Registration Performance: Scalability and Speed Across Enterprise Deployments

Certara Products, White Paper

Hidden data gaps in compound registration and drug discovery decisions

Certara Products, Discovery, Guide

Application of IO Simulator in Immuno-Oncology Combination Therapy: A Small Cell Lung Cancer Case Study

Biologics, Certara Services, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation - QSP, Therapeutic Specialties, Poster

Mechanistic Modelling of CRS in T-cell Engagers – An Application for Blinatumomab

Certara Services, Clinical Pharmacology, Drug Safety, Model Informed Drug Development, Modeling and Simulation - QSP, Therapeutic Specialties, Poster

Machine Learning based drug renal clearance predictor development and application

AI, Certara Products - Simcyp, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Poster

Accelerating QSP Virtual Population Generation Through Active Learning and Bayesian Optimization

Certara Services, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation, Poster

Chemaxon presents: Too Many Tools, Not Enough Chemistry

Certara Products, On-Demand Webinar

1
2
3
……
27
›

订阅时事通讯

为什么订阅？因为改变药物开发不仅是我们的目标，更是我们的执着追求。如果这也是您的想法，那么请第一时间了解新见解，与我们一起推动科学发展。

© 2026 Certara. 保留所有权力。 | 法律 | 隐私政策

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software